文献速递临床微生物分子诊断质量管理与危急值

可预防的患者伤害:多学科捆绑干预在采用谷氨酸脱氢酶/毒素免疫层析/核酸扩增检测算法下降低艰难梭菌感染

Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
PubMed 文献 · J Clin Microbiol · 2018-08-27

该研究关注医疗保健机构起病的艰难梭菌感染(HO-CDI),该机构自2009年使用两步法GDH/毒素免疫层析/NAAT算法,2016年设定到2017年7月将CDI率降低10%的组织目标。通过多学科团队实施并监测八类感染预防干预措施13个月,HO-CDI率实现42.7%的统计学显著下降,且未修改实验室算法。

要点

  • 在不改变高敏感实验室检测算法的情况下,通过多学科捆绑感染预防干预可显著降低HO-CDI率。
  • 该机构HO-CDI率下降42.7%,具有统计学显著性。
  • 干预措施涵盖八类关键感染预防干预,由多学科团队实施并监测13个月。

核心结论

  • 通过多学科捆绑感染预防干预可在不修改敏感实验室检测方法的情况下显著降低HO-CDI率。

研究设计与样本

  • 单中心机构质量改进项目,自2009年使用两步法GDH/毒素免疫层析/NAAT算法,2016年设定降低CDI率10%的目标,多学科团队实施并监测八类干预措施13个月。

主要发现

  • HO-CDI率实现42.7%的统计学显著下降,且未修改实验室算法。

关键数值与推荐

  • 组织目标为到2017年7月将CDI率降低10%;实际HO-CDI率下降42.7%。

临床怎么用

  • 检验科智能体医生可参考:维持现有高敏感检测算法,协同感染预防团队实施多学科捆绑干预以降低HO-CDI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Health care facility-onset Clostridium difficile infections (HO-CDI) are an important national problem, causing increased morbidity and mortality. HO-CDI is an important metric for the Center for Medicare and Medicaid Service's (CMS) performance measures. Hospitals that fall into the worst-performing quartile in preventing hospital-acquired infections, including HO-CDI, may lose millions of dollars in reimbursement. Under pressure to reduce CDI and without a clear optimal method for C. difficile detection, health care facilities are questioning how best to use highly sensitive nucleic acid amplification tests (NAATs) to aid in the diagnosis of CDI. Our institution has used a two-step glutamate dehydrogenase (GDH)/toxin immunochromatographic assay/NAAT algorithm since 2009. In 2016, our institution set an organizational goal to reduce our CDI rates by 10% by July 2017. We achieved a statistically significant reduction of 42.7% in our HO-CDI rate by forming a multidisciplinary group to implement and monitor eight key categories of infection prevention interventions over a period of 13 months. Notably, we achieved this reduction without modifying our laboratory algorithm. Significant reductions in CDI rates can be achieved without altering sensitive laboratory testing methods.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Schultz K, Sickbert-Bennett E, Marx A, et al. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm. J Clin Microbiol. 2018. PMID: 29997201. doi:10.1128/JCM.00625-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。